These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16418202)

  • 1. Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients.
    Tan FK; Zhou X; Mayes MD; Gourh P; Guo X; Marcum C; Jin L; Arnett FC
    Rheumatology (Oxford); 2006 Jun; 45(6):694-702. PubMed ID: 16418202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up regulated expression of tumour necrosis factor {alpha} converting enzyme in peripheral monocytes of patients with early systemic sclerosis.
    Bohgaki T; Amasaki Y; Nishimura N; Bohgaki M; Yamashita Y; Nishio M; Sawada KI; Jodo S; Atsumi T; Koike T
    Ann Rheum Dis; 2005 Aug; 64(8):1165-73. PubMed ID: 16014681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic sclerosis and lupus: points in an interferon-mediated continuum.
    Assassi S; Mayes MD; Arnett FC; Gourh P; Agarwal SK; McNearney TA; Chaussabel D; Oommen N; Fischbach M; Shah KR; Charles J; Pascual V; Reveille JD; Tan FK
    Arthritis Rheum; 2010 Feb; 62(2):589-98. PubMed ID: 20112391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?
    Farutin V; Kurtagic E; Pradines JR; Capila I; Mayes MD; Wu M; Manning AM; Assassi S
    Arthritis Res Ther; 2021 Oct; 23(1):259. PubMed ID: 34654463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
    York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
    Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach.
    Lunardi C; Dolcino M; Peterlana D; Bason C; Navone R; Tamassia N; Beri R; Corrocher R; Puccetti A
    PLoS Med; 2006 Jan; 3(1):e2. PubMed ID: 16318412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients.
    Higgs BW; Zhu W; Richman L; Fiorentino DF; Greenberg SA; Jallal B; Yao Y
    Int J Rheum Dis; 2012 Feb; 15(1):25-35. PubMed ID: 22324944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic sclerosis (scleroderma): specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts.
    Zhou X; Tan FK; Xiong M; Milewicz DM; Feghali CA; Fritzler MJ; Reveille JD; Arnett FC
    J Immunol; 2001 Dec; 167(12):7126-33. PubMed ID: 11739535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of altered microRNA expression profiles in peripheral blood mononuclear cells from patients with primary biliary cirrhosis.
    Qin B; Huang F; Liang Y; Yang Z; Zhong R
    J Gastroenterol Hepatol; 2013 Mar; 28(3):543-50. PubMed ID: 23173724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.
    Higgs BW; Liu Z; White B; Zhu W; White WI; Morehouse C; Brohawn P; Kiener PA; Richman L; Fiorentino D; Greenberg SA; Jallal B; Yao Y
    Ann Rheum Dis; 2011 Nov; 70(11):2029-36. PubMed ID: 21803750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of allograft inflammatory factor 1 in tissues from patients with systemic sclerosis and in vitro differential expression of its isoforms in response to transforming growth factor beta.
    Del Galdo F; Maul GG; Jiménez SA; Artlett CM
    Arthritis Rheum; 2006 Aug; 54(8):2616-25. PubMed ID: 16868985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cells.
    Avouac J; Cagnard N; Distler JH; Schoindre Y; Ruiz B; Couraud PO; Uzan G; Boileau C; Chiocchia G; Allanore Y
    Arthritis Rheum; 2011 Nov; 63(11):3552-62. PubMed ID: 21769840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature.
    Derrett-Smith EC; Martyanov V; Chighizola CB; Moinzadeh P; Campochiaro C; Khan K; Wood TA; Meroni PL; Abraham DJ; Ong VH; Lafyatis R; Whitfield ML; Denton CP
    Arthritis Res Ther; 2017 Jul; 19(1):156. PubMed ID: 28676069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular subtypes of systemic sclerosis in association with anti-centromere antibodies and digital ulcers.
    Bos CL; van Baarsen LG; Timmer TC; Overbeek MJ; Basoski NM; Rustenburg F; Baggen JM; Thiesen HJ; Dijkmans BA; van der Pouw Kraan TC; Voskuyl AE; Verweij CL
    Genes Immun; 2009 Apr; 10(3):210-8. PubMed ID: 19129850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients.
    Beretta L; Barturen G; Vigone B; Bellocchi C; Hunzelmann N; De Langhe E; Cervera R; Gerosa M; Kovács L; Ortega Castro R; Almeida I; Cornec D; Chizzolini C; Pers JO; Makowska Z; Lesche R; Kerick M; Alarcón-Riquelme ME; Martin J; ;
    Ann Rheum Dis; 2020 Sep; 79(9):1218-1226. PubMed ID: 32561607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monozygotic twins clinically discordant for scleroderma show concordance for fibroblast gene expression profiles.
    Zhou X; Tan FK; Xiong M; Arnett FC; Feghali-Bostwick CA
    Arthritis Rheum; 2005 Oct; 52(10):3305-14. PubMed ID: 16200604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein interaction for an interferon-inducible systemic lupus associated gene, IFIT1.
    Ye S; Pang H; Gu YY; Hua J; Chen XG; Bao CD; Wang Y; Zhang W; Qian J; Tsao BP; Hahn BH; Chen SL; Rao ZH; Shen N
    Rheumatology (Oxford); 2003 Oct; 42(10):1155-63. PubMed ID: 12777642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients.
    Giusti B; Fibbi G; Margheri F; Serratì S; Rossi L; Poggi F; Lapini I; Magi A; Del Rosso A; Cinelli M; Guiducci S; Kahaleh B; Bazzichi L; Bombardieri S; Matucci-Cerinic M; Gensini GF; Del Rosso M; Abbate R
    Arthritis Res Ther; 2006; 8(4):R115. PubMed ID: 16859528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal global transcriptomic profiling of preclinical systemic sclerosis reveals molecular changes associated with disease progression.
    Bellocchi C; Beretta L; Wang X; Lyons MA; Marchini M; Lorini M; Carbonelli V; Montano N; Assassi S
    Rheumatology (Oxford); 2023 Apr; 62(4):1662-1668. PubMed ID: 36040182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification analysis of the transcriptosome of nonlesional cultured dermal fibroblasts from systemic sclerosis patients with early disease.
    Tan FK; Hildebrand BA; Lester MS; Stivers DN; Pounds S; Zhou X; Wallis DD; Milewicz DM; Reveille JD; Mayes MD; Jin L; Arnett FC
    Arthritis Rheum; 2005 Mar; 52(3):865-76. PubMed ID: 15751056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.